Obesity-associated carcinogenesis is closely related to metabolic syndrome; hyperinsulinemia; visceral adipose dysfunction; aromatase activity and detrimental cytokine, adipokine and exosomal miRNA release. This evidence concerns the gene CYP19A1 and metabolic syndrome.